## ABNB: Airbnb, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -0.0% below STRENGTH zone (4.0-10.0%); PEG 1.81 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($114.72)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Airbnb CTO Aristotle N Balogh Sells Shares Under Trading Plan**
- Source: TradingView | 20251203T070939 | Somewhat-Bearish | Relevance: 100%
- Airbnb's Chief Technology Officer, Aristotle N Balogh, and Chief Strategy Officer, Nathan Blecharczyk, recently sold shares of the company's Class A Common Stock. Balogh sold 1,149 shares for a total of $133,731, while Blecharczyk sold 3,307 shares amounting to $385,959. These transactions were executed under pre-arranged Rule 10b5-1 trading plans.

**2. Analysts Conflicted on These Consumer Cyclical Names: Royal Caribbean (RCL) and Airbnb (ABNB)**
- Source: The Globe and Mail | 20251203T101045 | Bearish | Relevance: 100%
- This article highlights analyst opinions on two consumer cyclical companies: Royal Caribbean (RCL) and Airbnb (ABNB). Wells Fargo maintained a Buy rating for Royal Caribbean with a $316.00 price target, while Barclays also issued a Buy rating. Conversely, Wells Fargo analyst Ken Gawrelski maintained a Sell rating for Airbnb with a $118.00 price target.

**3. ABNB SEC Filings - Airbnb, Inc. 10-K, 10-Q, 8-K Forms**
- Source: Stock Titan | 20251203T070939 | Somewhat-Bearish | Relevance: 100%
- This article provides a comprehensive resource for Airbnb (ABNB) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), material events (8-K), and insider trading forms (Form 4). It highlights how Stock Titan uses AI to summarize these documents and offer real-time alerts and deep-dive analysis. The page also lists recent insider trading activities, such as sales by Elinor Mertz, Aristotle Balogh, and Joseph Gebbia, along with details about their transactions and the reasons behind them.

**4. Analysts Conflicted on These Consumer Cyclical Names: Royal Caribbean (RCL) and Airbnb (ABNB)**
- Source: The Globe and Mail | 20251202T122129 | Somewhat-Bearish | Relevance: 100%
- Analysts are divided on two major consumer cyclical companies, Royal Caribbean (RCL) and Airbnb (ABNB). Wells Fargo maintained a Buy rating on Royal Caribbean with a price target of $316.00, while also maintaining a Sell rating on Airbnb with a price target of $118.00. This results in a "Strong Buy" consensus for Royal Caribbean and a "Hold" consensus for Airbnb among analysts.

**5. Gilbert Cisneros conducts multiple transactions in stocks including Agios Pharmaceuticals and Airbnb**
- Source: Investing.com | 20251202T164400 | Somewhat-Bearish | Relevance: 100%
- Gilbert Cisneros, representative for California's 31st congressional district, has engaged in various stock transactions through the 150 Main Street Trust. His purchases included shares in Agios Pharmaceuticals, APi Group, Microsoft, CACI International, and Hawaiian Electric Industries, along with options in Broadcom and Constellation Brands. Cisneros also sold shares in Airbnb, Boeing, Broadcom, DENTSPLY SIRONA, Johnson & Johnson, and U.S. Treasury Bills.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Truist Securiti | $107 | $104 | +3% |
| 2025-12-01 | Wells Fargo | $118 | $111 | +6% |
| 2025-11-07 | Wells Fargo | $111 | $110 | +1% |
| 2025-11-07 | UBS | $147 | $145 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Truist Securiti | main | Sell |
| 2025-12-01 | Wells Fargo | main | Underweight |
| 2025-11-07 | Wells Fargo | main | Underweight |
| 2025-11-07 | UBS | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.00M) |
| Sells | 35 ($88.73M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.1% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.7%)
- Blackrock Inc.: 7.6% (+8.5%)
- State Street Corpora: 4.2% (-0.4%)
- Harris Associates L.: 3.6% (+8.6%)
- Morgan Stanley: 2.9% (-2.5%)

### Key Risks

1. Heavy insider selling: $89M sold (35 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 5 raises (avg +3%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.81 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 31%, margin 22%). Insider selling cluster ($88.7M in 90 days), potential headwind. Institutional flow bearish (4 selling vs 6 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $83.8B |
| Beta | 1.12 |
| 52W Range | $99.88 - $163.93 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.81 |
| Forward P/E | 25.0 |
| Current P/E | 29.3 |
| YoY Growth | 16.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.3% to -0.0% (+3.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.0pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.1%) - potential reversal signal. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (0.62), confirming momentum. RSI neutral at 53. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.03% (CS: 52) | Neutral |
| RSI_14 | 53.0 | Neutral |
| MACD Histogram | 0.62 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 0.993x | Below |
| vs SMA200 | 0.950x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $120.82
- **Stop Loss:** $114.72 (5.0% risk)
- **Target:** $126.92 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 163
- **Position Value:** $19,693.66
- **Portfolio %:** 19.69%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-12 (Est: $0.66)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.32 | $2.21 | -4.8% |
| 2025Q2 | $0.94 | $1.03 | +9.4% |
| 2025Q1 | $0.24 | $0.24 | +2.0% |
| 2024Q4 | $0.58 | $0.73 | +25.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*